Editas Medicine, Inc. - EDIT Market Capitalization

Public company logo of editasmedicine.com (EDIT)

The global genome editing sector is currently transitioning to a mass-market sales stage, where transplantation centers are driving primary demand. The infrastructure of Editas Medicine, Inc. (EDIT) is based on laboratories in Massachusetts and partnerships with US manufacturing plants. The quotes shown below, fixed at the level of 0.29, illustrate the dynamics of a business that is developing CRISPR therapy, monetizing patents, and seeking treatments for anemia.

EDIT (editasmedicine.com) Market Value history from 07/04/2022 to 11/17/2026

Editas Medicine, Inc. - analytical breakdowns and key metrics (EDIT)

Fundamental company analysis:editasmedicine.com EDIT
Original product of Editas Corp

The analyst assesses the credit quality of Editas Medicine, Inc. (EDIT) through the lens of liquidity and market confidence. The specifics of CRISPR therapy, characterized by patent wars and clinical risks, render the capitalization extremely volatile. The total market value of the business is calculated as the product of the current share price and the total number of outstanding shares. This indicator measures market capital density, reflecting investor expectations regarding the success of high-cost treatments. An increase in this metric absent fundamental achievements signals speculative risk.

Competitor analysis

Market Capitalization TEM (Tempus AI, Inc)|Market Capitalization Qiagen Group|IONS - Market Value|Market Value repligen.com|RNA: Market Capitalization|Market Valuation CRSP (CRISPR Therapeutics)|Market Value GeneDx Holdings Corp.|Market Capitalization RARE (Ultragenyx Corp)|Market Value Beam Therapeutics (BEAM)|Sarepta Therapeutics, Inc. - Market Capitalization|Market Capitalization TWST (twistbioscience.com)|Market Value TXG (10x Genomics Corp)|Intellia Corp - Market Capitalization|Market Capitalization Stoke Therapeutics STOK|BLFS: Market Capitalization|WVE (Wave Life Sciences) - Market Value|Market Valuation MAZE|Market Value Sionna Therapeutics, Inc. SION|Market Value Prime Medicine Bio (PRME)|Market Capitalization Taysha|uniQure Pharma - Market Valuation|Market Capitalization MeiraGTx Holdings plc MGTX|RGNX: Market Valuation|Market Value SLDB (Solid Biosciences)|OCGN (Ocugen Corp) - Market Valuation|Market Valuation Pacific Biosciences|Market Valuation BNTC|DSGN (Design Therapeutics) - Market Value|Market Capitalization RCKT|Market Value FDMT (4DMT)|Market Value Lexeo Therapeutics LXEO|Market Value KRRO|SLN - Market Value|PRQR - Market Capitalization|CDXS (Codexis, Inc.) - Market Valuation|Sangamo Therapeutics, Inc. - Market Value|Market Valuation NAUT|Market Valuation Metagenomi, Inc. (MGX)|Market Value precisionbiosciences.com (DTIL)|GBIO - Market Value|Market Capitalization BOLD (Boundless Bio Inc.)|Market Capitalization Exicure, Inc. XCUR|Imunon Inc - Market Capitalization|Market Capitalization phiopharma.com PHIO|Mustang Bio Corp (MBIO) - Market Value|Market Value TransCode Therapeutics (RNAZ)|BNGO (Bionano Genomics) - Market Capitalization|Market Valuation Applied DNA Sciences, Inc. (APDN)|Market Value Bluebird Bio (BLUE)|IPA - Market Value|Market Value omegatherapeutics.com OMGA|singulargenomics.com (OMIC) - Market Value|RGLS - Market Value|Market Capitalization Syros Pharmaceuticals Inc. SYRS|Telesis Bio, Inc. (TBIO) - Market Value|TCON - Market Capitalization|Market Value Unity Biotechnology, Inc.